The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease

Wnt/β-catenin is a signaling pathway associated with embryonic development, organ formation, cancer, and fibrosis. Its activation can repair kidney damage during acute kidney injury (AKI) and accelerate the occurrence of renal fibrosis after chronic kidney disease (CKD). Interestingly, p53 has also been found as a key modulator in AKI and CKD in recent years. Meantime, some studies have found crosstalk between Wnt/β-catenin signaling pathways and p53, but more evidence is required on whether they have synergistic effects in renal disease progression. This article reviews the role and therapeutic targets of Wnt/β-catenin and p53 in AKI and CKD and proposes for the first time that Wnt/β-catenin and p53 have a synergistic effect in the treatment of renal injury.

Authors

Institutions

Publication Details

Journal
Kidney Research and Clinical Practice
Published
2024-11-19
DOI
https://doi.org/10.23876/j.krcp.23.344
Citations
9
Primary Topic
Connective Tissue Growth Factor Research
Type
article
Field-Weighted Citation Impact
2.10

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease

Rongfang Qiao, Zhi‐Lin Luan, Bo-Wei Su, Yang Zhou et al.
9 citations
Kidney Research and Clinical Practice
Connective Tissue Growth Factor Research
2.10
article

The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease

Rongfang Qiao, Zhi‐Lin Luan, Bo-Wei Su, Yang Zhou, Yanan Bao, Wen-Juan Hu, Lin Wen, Wenhua Ming, Ping Gao
article en
9 citations

Abstract

Wnt/β-catenin is a signaling pathway associated with embryonic development, organ formation, cancer, and fibrosis. Its activation can repair kidney damage during acute kidney injury (AKI) and accelerate the occurrence of renal fibrosis after chronic kidney disease (CKD). Interestingly, p53 has also been found as a key modulator in AKI and CKD in recent years. Meantime, some studies have found crosstalk between Wnt/β-catenin signaling pathways and p53, but more evidence is required on whether they have synergistic effects in renal disease progression. This article reviews the role and therapeutic targets of Wnt/β-catenin and p53 in AKI and CKD and proposes for the first time that Wnt/β-catenin and p53 have a synergistic effect in the treatment of renal injury.

Kidney Research and Clinical PracticeVol. 43(6)
Capital Medical University (CN), Dalian Medical University (CN), Beijing Shijitan Hospital (CN)
Natural Science Foundation of Liaoning Province
Good health and well-being
Openalex Percentile: Top 12%
Connective Tissue Growth Factor Research
2.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.